| News |
|
| ||||||||
|
|
Nov 21-24, 2001 | |
|
|
MEDICA 2001, Düsseldorf, Germany. | |
|
| ||||||||
|
|
Jul 31-Aug 2, 2001 | |
|
|
AACC 2001 Clinical Laboratory Exposition, Chicago. | |
|
| ||||||||
|
|
July 25-27, 2000 | |
|
|
PBM exhibits at the 2000 American Association for Clinical Chemistry (AACC) Clinical Laboratory Exposition, July 25-27, 2000 in San Francisco, California. | |
|
| ||||||||
|
|
July 26, 1999 | |
|
|
PBM announces new products at the 1999
American Association for Clinical Chemistry
(AACC) Clinical Laboratory Exposition, July
26-29, 1999 in New Orleans, Louisiana:
BioSign™ H. pylori-CagA; AccuSign® Nicotine;
AccuSign® Caffeine; and the AccuStik™ format
of dipstick drugs of abuse tests. PBM also announces the following products are slated for future release: BioSign™ H. pylori Saliva test; BioSign™ Toxoplasmosis; BioSign™ HCV; BioSign™ Albumin; BioSign™ Ferritin; and BioSign™ sTfR. |
|
|
| ||||||||
|
|
July 21, 1997 | |
|
|
PBM announces new infectious disease assays at the 1997 American Association for Clinical Chemistry (AACC) Clinical Laboratory Exposition, July 21-24, 1997 in Atlanta, Georgia, including tests for malaria, tuberculosis, syphilis, toxoplasma gondii, and dengue. | |
|
| ||||||||
|
|
July 10, 1997 | |
|
|
The area code for PBM's telephone and fax numbers has changed from (908) to (732).
The new numbers are: telephone: (732) 274-1000 fax: (732) 274-1010 Please update your records accordingly. |
|
|
| ||||||||
|
|
July 8, 1997 | |
|
|
PBM announces its BioSign™ Strep A--Direct Strep A Antigen Test has received FDA 510(k) marketing approval. The product is available immediately in the United States and other countries. | |
|
| ||||||||
|
|
|
| All contents copyright © 1997-2001 Princeton BioMeditech Corporation. All rights reserved. Terms of Use |